Influence of infection route and virulence factors on colonization of solid tumors by Salmonella enterica serovar Typhimurium

FEMS Immunology and Medical Microbiology

Volumn 62, Issue 1, 2011, Pages 75-83

  Crull, Katja ^a   Bumann, Dirk ^b   Weiss, Siegfried ^a  

^a HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

^b UNIVERSITY OF BASEL   (Switzerland)

Author keywords

Mutants; Salmonella typhimurium; Tumor colonization; Virulence factors

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BACTERIAL VIRULENCE; CANCER INVASION; CHEMOTAXIS; CONTROLLED STUDY; FEMALE; MOUSE; NONHUMAN; PATHOGENICITY ISLAND; PRIORITY JOURNAL; SALMONELLA ENTERICA; SALMONELLA TYPHIMURIUM; SEROTYPE; SOLID TUMOR; TYPHOID FEVER;

ADMINISTRATION, ORAL; ANIMALS; CARCINOMA; COLONIC NEOPLASMS; DRUG ADMINISTRATION ROUTES; FEMALE; INJECTIONS, INTRAPERITONEAL; INJECTIONS, INTRAVENOUS; MICE; MICE, INBRED BALB C; NEOPLASMS, EXPERIMENTAL; SALMONELLA TYPHIMURIUM; TREATMENT OUTCOME; VIRULENCE; VIRULENCE FACTORS;

EID: 79955046293     PISSN: 09288244     EISSN: 1574695X     Source Type: Journal    
DOI: 10.1111/j.1574-695X.2011.00790.x     Document Type: Article

References (37)

1. Avogadri F, Martinoli C, Petrovska L, Chiodoni C, Transidico P, Bronte V, Longhi R, Colombo MP, Dougan G & Rescigno M (2005) Cancer immunotherapy based on killing of Salmonella-infected tumor cells. Cancer Res 65: 3920-3927.
2. Barthel M, Hapfelmeier S, Quintanilla-Martinez L, Kremer M, Rohde M, Hogardt M, Pfeffer K, Russmann H & Hardt WD (2003) Pretreatment of mice with streptomycin provides a Salmonella enterica serovar Typhimurium colitis model that allows analysis of both pathogen and host. Infect Immun 71: 2839-2858.
3. Bueno SM, Tobar JA, Iruretagoyena MI & Kalergis AM (2005) Molecular interactions between dendritic cells and Salmonella: escape from adaptive immunity and implications on pathogenesis. Crit Rev Immunol 25: 389-403.
4. Cirillo DM, Valdivia RH, Monack DM & Falkow S (1998) Macrophage-dependent induction of the Salmonella pathogenicity island 2 type III secretion system and its role in intracellular survival. Mol Microbiol 30: 175-188.
5. Clairmont C, Lee KC, Pike J et al. (2000) Biodistribution and genetic stability of the novel antitumor agent VNP20009, a genetically modified strain of Salmonella typhimurium. J Infect Dis 181: 1996-2002.
6. Coley WB (1893) The treatment of malignant tumors by repeated inoculations of erysipelas. With a report of ten original cases. Clin Orthop Relat R 262: 3-11.
7. Datsenko KA & Wanner BL (2000) One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. P Natl Acad Sci USA 97: 6640-6645.
8. Fest S, Huebener N, Bleeke M et al. (2009) Survivin minigene DNA vaccination is effective against neuroblastoma. Int J Cancer 125: 104-114.
9. Finlay BB & Brumell JH (2000) Salmonella interactions with host cells: in vitro to in vivo. Philos T R Soc B 355: 623-631.
10. Forbes NS, Munn LL, Fukumura D & Jain RK (2003) Sparse initial entrapment of systemically injected Salmonella typhimurium leads to heterogeneous accumulation within tumors. Cancer Res 63: 5188-5193.
11. Gunn JS (2008) The Salmonella PmrAB regulon: lipopolysaccharide modifications, antimicrobial peptide resistance and more. Trends Microbiol 16: 284-290.
12. Hapfelmeier S, Stecher B, Barthel M et al. (2005) The Salmonella pathogenicity island (SPI)-2 and SPI-1 type III secretion systems allow Salmonella serovar typhimurium to trigger colitis via MyD88-dependent and MyD88-independent mechanisms. J Immunol 174: 1675-1685.
13. Hayashi K, Zhao M, Yamauchi K, Yamamoto N, Tsuchiya H, Tomita K & Hoffman RM (2009) Cancer metastasis directly eradicated by targeted therapy with a modified Salmonella typhimurium. J Cell Biochem 106: 992-998.
14. Hoiseth SK & Stocker BA (1981) Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines. Nature 291: 238-239.
15. Jones BD, Lee CA & Falkow S (1992) Invasion by Salmonella typhimurium is affected by the direction of flagellar rotation. Infect Immun 60: 2475-2480.
16. Jones MA, Hulme SD, Barrow PA & Wigley P (2007) The Salmonella pathogenicity island 1 and Salmonella pathogenicity island 2 type III secretion systems play a major role in pathogenesis of systemic disease and gastrointestinal tract colonization of Salmonella enterica serovar Typhimurium in the chicken. Avian Pathol 36: 199-203.
17. Kasinskas RW & Forbes NS (2006) Salmonella typhimurium specifically chemotax and proliferate in heterogeneous tumor tissue in vitro. Biotechnol Bioeng 94: 710-721.
18. Kasinskas RW & Forbes NS (2007a) Salmonella typhimurium lacking ribose chemoreceptors localize in tumor quiescence and induce apoptosis. Cancer Res 67: 3201-3209.
19. Kasinskas RW & Forbes NS (2007b) Salmonella typhimurium lacking ribose chemoreceptors localize in tumor quiescence and induce apoptosis. Cancer Res 67: 3201-3209.
20. Kimura H, Zhang L, Zhao M, Hayashi K, Tsuchiya H, Tomita K, Bouvet M, Wessels J & Hoffman RM (2010) Targeted therapy of spinal cord glioma with a genetically modified Salmonella typhimurium. Cell Proliferat 43: 41-48.
21. Leschner S & Weiss S (2010) Salmonella- allies in the fight against cancer. J Mol Med 88: 763-773.
22. Leschner S, Westphal K, Dietrich N et al. (2009) Tumor invasion of Salmonella enterica serovar Typhimurium is accompanied by strong hemorrhage promoted by TNF-alpha. PLoS One 4: 6692.
23. Loessner H, Endmann A, Leschner S, Westphal K, Rohde M, Miloud T, Hammerling G, Neuhaus K & Weiss S (2007a) Remote control of tumour-targeted Salmonella enterica serovar Typhimurium by the use of l-arabinose as inducer of bacterial gene expression in vivo. Cell Microbiol 9: 1529-1537.
24. Main-Hester KL, Colpitts KM, Thomas GA, Fang FC & Libby SJ (2008) Coordinate regulation of Salmonella pathogenicity island 1 (SPI1) and SPI4 in Salmonella enterica serovar Typhimurium. Infect Immun 76: 1024-1035.
25. Medina E, Guzman CA, Staendner LH, Colombo MP & Paglia P (1999) Salmonella vaccine carrier strains: effective delivery system to trigger anti-tumor immunity by oral route. Eur J Immunol 29: 693-699.
26. Panthel K, Meinel KM, Sevil DV, Trulzsch K & Russmann H (2008) Salmonella type III-mediated heterologous antigen delivery: a versatile oral vaccination strategy to induce cellular immunity against infectious agents and tumors. Int J Med Microbiol 298: 99-103.
27. Pawelek JM, Low KB & Bermudes D (1997a) Tumor-targeted Salmonella as a novel anticancer vector. Cancer Res 57: 4537-4544.
28. Pawelek JM, Sodi S, Chakraborty AK, Platt JT, Miller S, Holden DW, Hensel M & Low KB (2002a) Salmonella pathogenicity island-2 and anticancer activity in mice. Cancer Gene Ther 9: 813-818.
29. Rosenberg SA, Spiess PJ & Kleiner DE (2002) Antitumor effects in mice of the intravenous injection of attenuated Salmonella typhimurium. J Immunother 25: 218-225.
30. Stecher B, Hapfelmeier S, Muller C, Kremer M, Stallmach T & Hardt WD (2004) Flagella and chemotaxis are required for efficient induction of Salmonella enterica serovar Typhimurium colitis in streptomycin-pretreated mice. Infect Immun 72: 4138-4150.
31. Stritzker J, Weibel S, Seubert C, Gotz A, Tresch A, van Rooijen N, Oelschlaeger TA, Hill PJ, Gentschev I & Szalay AA (2010) Enterobacterial tumor colonization in mice depends on bacterial metabolism and macrophages but is independent of chemotaxis and motility. Int J Med Microbiol 300: 449-456.
32. Toso JF, Gill VJ, Hwu P et al. (2002) Phase I study of the intravenous administration of attenuated Salmonella typhimurium to patients with metastatic melanoma. J Clin Oncol 20: 142-152.
33. Waterman SR & Holden DW (2003) Functions and effectors of the Salmonella pathogenicity island 2 type III secretion system. Cell Microbiol 5: 501-511.
34. Westphal K, Leschner S, Jablonska J, Loessner H & Weiss S (2008) Containment of tumor-colonizing bacteria by host neutrophils. Cancer Res 68: 2952-2960.
35. Wray C & Sojka WJ (1978) Experimental Salmonella typhimurium infection in calves. Res Vet Sci 25: 139-143.
36. Zhao M, Yang M, Li XM, Jiang P, Baranov E, Li S, Xu M, Penman S & Hoffman RM (2005) Tumor-targeting bacterial therapy with amino acid auxotrophs of GFP-expressing Salmonella typhimurium. P Natl Acad Sci USA 102: 755-760.
37. Zhao M, Yang M, Ma H, Li X, Tan X, Li S, Yang Z & Hoffman RM (2006) Targeted therapy with a Salmonella typhimurium leucine-arginine auxotroph cures orthotopic human breast tumors in nude mice. Cancer Res 66: 7647-7652.